William Lee

机构：AST Products (United States), Powertech Technology (Taiwan), Helix (United States), Drexel University, University of Pennsylvania, Philadelphia University · ORCID：0000-0001-9582-4413

发表论文 266 篇 · 总被引 41720 次 · h-index 56

代表论文

• XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants (2025 · Frontiers in Immunology · 被引 3)
• Evaluation of physiological bone metabolic activity in the spine with 18F-fluorodeoxyglucose and 18F-sodium fluoride PET: associations with degenerative risk factors (2026 · Nuclear Medicine Communications · 被引 2)
• Novel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse Cohort (2025 · JACC Basic to Translational Science · 被引 2)
• Population Genomic Screening and Improved Lipid Management in Patients With Familial Hypercholesterolemia (2025 · Circulation Genomic and Precision Medicine · 被引 1)
• 976P HM97662, a novel EZH1/2 dual inhibitor, in patients with advanced or metastatic solid tumors: Initial results from a first-in-human phase I study (2025 · Annals of Oncology · 被引 1)
• Spinal cord FDG PET uptake in healthy adults: an AI-driven segmentation study (2026 · European Spine Journal)